Smith & Nephew, a global medical technology business, has named Namal Nawana as its new chief executive officer, it was reported yesterday.
Nawana has joined the company from medical diagnostics company, Alere, where he was also chief executive officer, and managed its USD5.3bn acquisition by Abbott last year. Prior to Alere, Nawana spent more than 15 years at Johnson & Johnson, primarily in its medical devices and diagnostics segment.
Roberto Quarta, chairman of Smith & Nephew, said, 'Namal has the experience as a CEO of a major listed company in the healthcare sector, and has demonstrated that he can energise businesses to deliver better performance and greater value to shareholders.'
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer